Cargando…
Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have no...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129171/ https://www.ncbi.nlm.nih.gov/pubmed/34017842 http://dx.doi.org/10.3389/fmed.2021.644195 |
_version_ | 1783694269452648448 |
---|---|
author | Nakamura, Kensuke Nakano, Hidehiko Naraba, Hiromu Mochizuki, Masaki Takahashi, Yuji Sonoo, Tomohiro Hashimoto, Hideki Abe, Toshikazu Hayakawa, Mineji Yamakawa, Kazuma |
author_facet | Nakamura, Kensuke Nakano, Hidehiko Naraba, Hiromu Mochizuki, Masaki Takahashi, Yuji Sonoo, Tomohiro Hashimoto, Hideki Abe, Toshikazu Hayakawa, Mineji Yamakawa, Kazuma |
author_sort | Nakamura, Kensuke |
collection | PubMed |
description | Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have not yet been examined. Since the half-life of vasopressin is longer than that of catecholamines, we hypothesized that vasopressin loading may be effective for predicting responses to its continuous administration. Methods: We retrospectively analyzed consecutive cases of septic shock for which vasopressin was introduced with loading under noradrenaline at >0.2 μg/kg/min during the study period. Vasopressin was administered in a 1 U bolus followed by its continuous administration at 1 U/h. The proportion of patients with a negative catecholamine index (CAI) change 6 h after the introduction of vasopressin was set as the primary outcome. We defined non-responders for exploration as those with a mean arterial pressure change <18 mmHg 1 min after vasopressin loading, among whom none had a change in CAI <0. Results: Twenty-one consecutive cases were examined in the present study, and included 14 responders and 7 non-responders. The primary outcome accounted for 71.4% of responders and 0% of non-responders, with a significant difference (p = 0.0039). Median CAI changes 2, 4, and 6 h after the administration of vasopressin were 0, −5, and −10 in responders and +20, +10, and +10 in non-responders, respectively. CAI was not reduced in any non-responder. Outcomes including mortality were not significantly different between responders and non-responders. Digital ischemia (1/21) and mesenteric ischemia (1/21) were observed. Conclusions: Vasopressin loading may predict responses to its continuous administration in septic shock patients. Further investigations involving a safety analysis are needed. |
format | Online Article Text |
id | pubmed-8129171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81291712021-05-19 Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series Nakamura, Kensuke Nakano, Hidehiko Naraba, Hiromu Mochizuki, Masaki Takahashi, Yuji Sonoo, Tomohiro Hashimoto, Hideki Abe, Toshikazu Hayakawa, Mineji Yamakawa, Kazuma Front Med (Lausanne) Medicine Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have not yet been examined. Since the half-life of vasopressin is longer than that of catecholamines, we hypothesized that vasopressin loading may be effective for predicting responses to its continuous administration. Methods: We retrospectively analyzed consecutive cases of septic shock for which vasopressin was introduced with loading under noradrenaline at >0.2 μg/kg/min during the study period. Vasopressin was administered in a 1 U bolus followed by its continuous administration at 1 U/h. The proportion of patients with a negative catecholamine index (CAI) change 6 h after the introduction of vasopressin was set as the primary outcome. We defined non-responders for exploration as those with a mean arterial pressure change <18 mmHg 1 min after vasopressin loading, among whom none had a change in CAI <0. Results: Twenty-one consecutive cases were examined in the present study, and included 14 responders and 7 non-responders. The primary outcome accounted for 71.4% of responders and 0% of non-responders, with a significant difference (p = 0.0039). Median CAI changes 2, 4, and 6 h after the administration of vasopressin were 0, −5, and −10 in responders and +20, +10, and +10 in non-responders, respectively. CAI was not reduced in any non-responder. Outcomes including mortality were not significantly different between responders and non-responders. Digital ischemia (1/21) and mesenteric ischemia (1/21) were observed. Conclusions: Vasopressin loading may predict responses to its continuous administration in septic shock patients. Further investigations involving a safety analysis are needed. Frontiers Media S.A. 2021-05-04 /pmc/articles/PMC8129171/ /pubmed/34017842 http://dx.doi.org/10.3389/fmed.2021.644195 Text en Copyright © 2021 Nakamura, Nakano, Naraba, Mochizuki, Takahashi, Sonoo, Hashimoto, Abe, Hayakawa and Yamakawa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Nakamura, Kensuke Nakano, Hidehiko Naraba, Hiromu Mochizuki, Masaki Takahashi, Yuji Sonoo, Tomohiro Hashimoto, Hideki Abe, Toshikazu Hayakawa, Mineji Yamakawa, Kazuma Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title_full | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title_fullStr | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title_full_unstemmed | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title_short | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series |
title_sort | vasopressin loading for refractory septic shock: a preliminary analysis of a case series |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129171/ https://www.ncbi.nlm.nih.gov/pubmed/34017842 http://dx.doi.org/10.3389/fmed.2021.644195 |
work_keys_str_mv | AT nakamurakensuke vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT nakanohidehiko vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT narabahiromu vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT mochizukimasaki vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT takahashiyuji vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT sonootomohiro vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT hashimotohideki vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT abetoshikazu vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT hayakawamineji vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries AT yamakawakazuma vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries |